YOU CAN’T BEAT THE DISEASES YOU CAN’T SEE.
Over the past decade, significant technological advances in
radiotherapy have come into clinical practice. However, limitations such as poor soft tissue contrast and having no real-time imaging during beam-on have constrained potentially safer and more effective radiation doses.
Combining the latest innovations in precision radiation delivery with ground-breaking MR image guidance and on-table adaptive therapy, it’s time for the next big advance in radiation oncology— MRIdian®
The future of radiation therapy is clear.
Simultaneous Imaging and Treatment
It is a simple truth. Voluntary and involuntary lifesustaining movements don’t stop while your patients are receiving radiation therapy. As your patient moves, the tumor and healthy organs move too preventing accurate treatment and sparing of healthy tissues!
At ViewRay , we understand that the best way to deliver an accurate dose of radiation to a moving target is to be able to see inside the body at the time of treatment. That is why we designed MRIdian , the world’s first and only MRI-Guided Radiation Therapy System that can image and treat cancer patients simultaneously. MRIdian was an early breakthrough allowing the world’s first clinical MRI guided radiation treatments, having treated over 1,200 patients in clinics worldwide.
MRIdian’s SmartVISION delivers high-definition, diagnostic-quality imaging designed specifically to maintain high-fidelity beam delivery while virtually eliminating the risks of skin toxicities, trapped or distorted dose and other concerns that may occur when high magnetic fields interact with radiation beams.
MRIdian shapes the dose to fit the day. It’s the only MR solution that enables integrated adaptive treatment for on-table reoptimization of the daily treatment plan.
MRIdian captures 8 frames per second, leveraging high-contrast anatomical detail to rapidly reshape dose delivery based on the current position of both the tumor and adjacent critical structures – all while the patient is in the treatment position.
MRIdian knows when to strike, visualizing the tumor’s edges and surrounding organ position in real time.
It’s the only RT solution with automated beam gating for precise and accurate dosing. When the tumor moves, the beam stops. Clinicians can shrink margins with confidence while escalating dose and reducing fractions.
Able to fit within almost any existing standard linear accelerator vault, MRIdian’s compact SmartSITE footprint addresses common physical space limitations and avoids the excessive delays, interruptions, and costs necessary to remove walls or build custom, large-scale vaults.